home / stock / rvnc / rvnc news

RVNC News and Press, Revance Therapeutics Inc. From 02/02/24

Stock Information
Company Name: Revance Therapeutics Inc.
Stock Symbol: RVNC
Market: NASDAQ
Website: revance.com
Menu
RVNC RVNC Quote RVNC Short RVNC News RVNC Articles RVNC Message Board
Get RVNC Alerts

News, Short Squeeze, Breakout and More Instantly...
RVNC - KOPN, RVNC and MINM are among pre market gainers

2024-02-02 08:32:47 ET CCSC Technology International Holdings  ( CCTG ) +39% . Minim  ( MINM ) +38% . TruGolf Holdings  ( TRUG ) +36% . Kopin  ( KOPN ) +21% . Meta Platforms  ( META ) +17% Q4 earnings call rele...
RVNC - Revance Receives Permanent J-Code for DAXXIFY® and Announces Publication of DAXXIFY Pivotal Study (ASPEN-1) Results in Neurology®

- CMS streamlines reimbursement for DAXXIFY with assignment of permanent J-code - - Peer-reviewed publication of DAXXIFY pivotal data in therapeutics reinforces the products long duration of effect and favorable safety profile - Revance Therapeutics, Inc. (RVNC) today announ...

RVNC - Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference

Revance Therapeutics, Inc. (RVNC), today announced that the company will be participating in the Guggenheim Healthcare Talks, 6 th Annual Biotechnology Conference, taking place February 7-8, 2024, in New York, New York. Chief Executive Officer, Mark J. Foley, is scheduled to participate in ...

RVNC - Revance falls after Mizuho downgrades citing "too high guidance"

2024-01-29 09:00:19 ET NASDAQ: RVNC 3.5% More on Revance Therapeutics Revance Therapeutics: Not Even Daxxify Can Treat Investor Frown Lines Revance Therapeutics, Inc. (RVNC) Q3 2023 Earnings Call Transcript Revance Therapeutics expects to achieve positive...
RVNC - KNDI, NVCR and LBTYA are among after hour movers

2024-01-12 16:40:04 ET Gainers: Outset Medical ( OM ) +11% . Kandi Technologies Group ( KNDI ) +7% . Dyne Therapeutics ( DYN ) +5% . Revance Therapeutics ( RVNC ) +4% . NovoCure Limited ( NVCR ) +3% . Losers: Gritstone&#x...

RVNC - How to Take Advantage of moves in (RVNC)

2024-01-11 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

RVNC - AbbVie sees maintaining Botox position in aesthetics: report

2024-01-10 16:46:06 ET More on AbbVie AbbVie Inc. (ABBV) J.P. Morgan 42nd Annual Healthcare Conference AbbVie: Still Expensive Despite The Great M&A Acumen Investor's Dilemma: AbbVie Stock Amidst U.S. Election And Humira Decline AbbVie announces EU availa...
RVNC - SNMP, VERO and PRAX among mid-day movers

2024-01-08 12:31:25 ET Gainers: Harpoon Therapeutics ( HARP ) +112% . Ambrx Biopharma ( AMAM ) +101% . Nkarta ( NKTX ) +47% . Mountain Crest Acquisition Corp IV ( MCAF ) +45% . Spectaire Holdings ( SPEC ) +43% . Neximmune ( ...

RVNC - Revance Therapeutics expects to achieve positive adj EBITDA in 2025

2024-01-08 11:47:12 ET More on Revance Therapeutics Revance Therapeutics: Not Even Daxxify Can Treat Investor Frown Lines Revance Therapeutics, Inc. (RVNC) Q3 2023 Earnings Call Transcript Public Citizen petitions FDA for stricter warnings against Botox, similar drug...

RVNC - Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook

– Q4 DAXXIFY® volume sold up 22% over Q3, reflecting positive feedback on the product’s performance profile and the new pricing strategy. – Preliminary unaudited Q4 and full year 2023 product revenue (DAXXIFY and RHA® Collection) of between $58 million and $59 m...
Previous 10 Next 10